Johnson & Johnson to Host Q4 2025 Earnings Conference Call at 8:30 AM ET on January 22, 2026

Johnson & Johnson will hold its quarterly earnings conference call at 8:30 AM Eastern Time on January 22, 2026, to discuss financial results for the fourth quarter and full year 2025. The company will provide updates on revenue, adjusted earnings per share, and strategic initiatives across its pharmaceutical, medical devices, and consumer health segments. The call will be accessible via live webcast on Johnson & Johnson’s investor relations website. Management will also release a press release with detailed financials prior to the call. Investors are advised to review the accompanying earnings presentation and supplemental financial data, which include segment performance, guidance for 2026, and capital allocation plans. The event is expected to draw attention from institutional investors due to ongoing pipeline developments and recent regulatory milestones in key markets.